Results 211 to 220 of about 46,126 (242)

Alkylating agents and cancer therapy

Expert Opinion on Therapeutic Patents, 2007
Ranju Ralhan, Jatinder Kaur
exaly  

Balancing repair and tolerance of DNA damage caused by alkylating agents

Nature Reviews Cancer, 2012
Jennifer A Calvo, Leona D Samson, Samson Leona D   +2 more
exaly  

With Alkylating Agents

2008
Y. Tang, X.-L. Sun
openaire   +1 more source

From old alkylating agents to new minor groove binders

Critical Reviews in Oncology/Hematology, 2014
Philippe Pourquier
exaly  

Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agents

American Journal of Hematology, 1980
Gerald H Clamon, Michael P Corder, C Patrick Burns   +2 more
exaly  

Rethinking Alkylating(-Like) Agents for Solid Tumor Management

Trends in Pharmacological Sciences, 2019
Hélène Lajous, Elodie Vauleon, Philippe Lecomte   +2 more
exaly  

Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan

Expert Opinion on Drug Metabolism and Toxicology, 2013
Ariane Galaup, Angelo Paci
exaly  

Alkylating agents

Reactions Weekly, 2017
openaire   +1 more source

RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE

Lancet, The, 1987
Jens Pedersen-Bjergaard, Severin Olesen Larsen, Lena Specht   +2 more
exaly  

Alkylating agents

Reactions, 1983
openaire   +1 more source